Ovid Therapeutics Inc (OVID) Stock Price, Quote, News & History

OVIDNASDAQ
$2.88
-0.03-1.03%
At close: Aug 25, 5:00 PM EST
$2.89
-0.02-0.69%
Pre-Market: 7:00 AM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-54.77M
Investing Cash Flow (TTM)
-147.80M
Financing Cash Flow (TTM)
185.78M
Free Cash Flow (TTM)
-54.77M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-16.80M

Analyst Trends and Forecast

2
Mar
2
Apr
1
Aug
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$456.00M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
220.34
PB Ratio (TTM)
2.67
Earnings Yield % (TTM)
-7.32%
Earnings Yield % (FWD)
-14.29%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$1.07

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$11.33M
Debt to Equity
0.06
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
-
Close
$2.88
Volume / Avg.
115.00 / 2.26M
Day Range
- - -
52 Wk Range
1.12 - 3.11
Market Cap
$564.41M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
61
Short Interest
12.69%
Days to Cover
15.18

About

Sector
Health Care
Industry
Biotechnology
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated ...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Ovid Therapeutics (OVID) stock?

A

You can purchase shares of Ovid Therapeutics (NASDAQ:OVID) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Ovid Therapeutics (OVID) competitors?

Q

What is the forecast, or price target, for Ovid Therapeutics (OVID) stock?

A

Ovid Therapeutics has a consensus price target of $4.42.

Q

What is the current price for Ovid Therapeutics (OVID)?

A

The stock price for Ovid Therapeutics (NASDAQ: OVID) is $2.89 last updated August 27, 2026 at 7:00 AM EDT.

Q

Does Ovid Therapeutics (OVID) pay a dividend?

A

There are no upcoming dividends for Ovid Therapeutics.

Q

When is Ovid Therapeutics (NASDAQ:OVID) reporting earnings?

A

Ovid Therapeutics does not have any upcoming earnings scheduled.

Q

Is Ovid Therapeutics (OVID) going to split?

A

There is no upcoming split for Ovid Therapeutics.

Q

What sector and industry does Ovid Therapeutics (OVID) operate in?

A

Ovid Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.